Cidara Therapeutics Inc (CDTX) — Free Cash Flow Generation Index
Latest as of June 2023:
0.96x
Cidara Therapeutics Inc (CDTX) has a Free Cash Flow Generation Index of 0.96x as of June 2023. Free cash flow of $2.71 Million represents 1% of operating cash flow ($2.82 Million). Explore reinvestment intensity of Cidara Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.96x
Free Cash Flow / Operating CF
Free Cash Flow
$2.71 Million
USD
Operating Cash Flow
$2.82 Million
USD
Capital Expenditures
$107.00K
USD
Annual Free Cash Flow Generation for Cidara Therapeutics Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Cidara Therapeutics Inc. Check CDTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).